SYMDEKO PAK Trademark

Trademark Overview

On Wednesday, October 26, 2016, a trademark application was filed for SYMDEKO PAK with the United States Patent and Trademark Office. The USPTO has given the SYMDEKO PAK trademark a serial number of 87215874. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, June 8, 2020. This trademark is owned by Vertex Pharmaceuticals Incorporated. The SYMDEKO PAK trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of cystic fibrosis
symdeko pak

General Information

Serial Number87215874
Word MarkSYMDEKO PAK
Filing DateWednesday, October 26, 2016
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, June 8, 2020
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, March 7, 2017

Trademark Statements

Disclaimer with Predetermined Text"PACK"
Goods and ServicesPharmaceutical preparations for the treatment of cystic fibrosis

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, October 31, 2016
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameVertex Pharmaceuticals Incorporated
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressBoston, MA 02210
Party NameVertex Pharmaceuticals Incorporated
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressBoston, MA 02210

Trademark Events

Event DateEvent Description
Monday, June 8, 2020ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, June 8, 2020ABANDONMENT - NO USE STATEMENT FILED
Wednesday, November 6, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, November 5, 2019EXTENSION 5 GRANTED
Thursday, October 31, 2019EXTENSION 5 FILED
Monday, November 4, 2019CASE ASSIGNED TO INTENT TO USE PARALEGAL
Thursday, October 31, 2019TEAS EXTENSION RECEIVED
Friday, July 5, 2019ASSIGNED TO EXAMINER
Thursday, May 2, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, April 30, 2019EXTENSION 4 GRANTED
Tuesday, April 30, 2019EXTENSION 4 FILED
Tuesday, April 30, 2019TEAS EXTENSION RECEIVED
Thursday, October 25, 2018NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, October 23, 2018EXTENSION 3 GRANTED
Tuesday, October 23, 2018EXTENSION 3 FILED
Tuesday, October 23, 2018TEAS EXTENSION RECEIVED
Thursday, May 3, 2018NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, May 1, 2018EXTENSION 2 GRANTED
Tuesday, May 1, 2018EXTENSION 2 FILED
Tuesday, May 1, 2018TEAS EXTENSION RECEIVED
Friday, November 3, 2017NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, November 1, 2017EXTENSION 1 GRANTED
Wednesday, November 1, 2017EXTENSION 1 FILED
Wednesday, November 1, 2017TEAS EXTENSION RECEIVED
Tuesday, May 2, 2017NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, March 7, 2017OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, March 7, 2017PUBLISHED FOR OPPOSITION
Wednesday, February 15, 2017NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Thursday, January 5, 2017APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, January 5, 2017EXAMINER'S AMENDMENT ENTERED
Thursday, January 5, 2017NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Thursday, January 5, 2017EXAMINERS AMENDMENT E-MAILED
Thursday, January 5, 2017EXAMINERS AMENDMENT -WRITTEN
Wednesday, January 4, 2017ASSIGNED TO EXAMINER
Monday, October 31, 2016NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Saturday, October 29, 2016NEW APPLICATION ENTERED IN TRAM

Related Keywords

symdeko fibrosis cystic treatment preparations pharmaceutical